Current approaches to the diagnosis and treatment of cholangiocarcinoma

Malignancies arising from biliary tract epithelia, or cholangiocarcinoma, are rare tumors that have a poor prognosis. The incidence of these tumors is gradually increasing in many countries. Recent advances have been made in identifying some of the risk factors, and the need for appropriate classification is emerging. The diagnosis of cholangiocarcinoma is often difficult and requires multiple complementary studies. The use of molecular approaches may improve the diagnostic utility of biliary cytology. Treatment of these tumors is complex, and there are many different treatment options. Although surgical resection can be curative, many patients with cholangiocarcinoma are diagnosed at an advanced stage when only palliative approaches can be used. Photodynamic therapy is emerging as a useful modality.

[1]  M. Nagino,et al.  Management of Hilar Cholangiocarcinoma: Comparison of an American and a Japanese Experience , 2000, Annals of surgery.

[2]  W. Jarnagin,et al.  Surgical management of cholangiocarcinoma. , 2004, Seminars in liver disease.

[3]  J. Vauthey,et al.  Recent Advances in the Management of Cholangiocarcinomas , 1994, Seminars in liver disease.

[4]  M. Pruckmayer,et al.  The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. , 1998, European journal of cancer.

[5]  P. Schein,et al.  5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Schoefl,et al.  Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. , 1997, Scandinavian journal of gastroenterology.

[7]  K. Takeda,et al.  Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers. , 2000, Gastrointestinal endoscopy.

[8]  H. Thomas,et al.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.

[9]  B. Malassagne,et al.  Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. , 2000, Archives of surgery.

[10]  M. Nagino,et al.  Lymph Node Metastasis from Hilar Cholangiocarcinoma: Audit of 110 Patients Who Underwent Regional and Paraaortic Node Dissection , 2001, Annals of surgery.

[11]  Michael Gregor,et al.  Serum and bile markers for cholangiocarcinoma. , 2004, Seminars in liver disease.

[12]  J. Lee,et al.  Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  K. Lillemoe,et al.  Perihilar Cholangiocarcinoma Postoperative Radiotherapy Does Not Improve Survival , 1995, Annals of surgery.

[14]  G. Fiorentini,et al.  Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5‐fluorouracil in patients with unresectable biliary tract tumors , 2005, Cancer.

[15]  R. Jenkins,et al.  Aggressive surgical resection for cholangiocarcinoma. , 1995, Archives of surgery.

[16]  K. Ido,et al.  Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy. , 1998, Gastrointestinal endoscopy.

[17]  W. Silverman,et al.  Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. , 2002, Gastrointestinal endoscopy.

[18]  M. Tillich,et al.  Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. , 1998, AJR. American journal of roentgenology.

[19]  K. Lillemoe,et al.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. , 1996, Annals of surgery.

[20]  M. Gonen,et al.  Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma , 2001, Annals of surgery.

[21]  M. Makuuchi,et al.  A new staging system for mass‐forming intrahepatic cholangiocarcinoma , 2001, Cancer.

[22]  R. Manfredi,et al.  Magnetic resonance imaging of cholangiocarcinoma. , 2004, Seminars in liver disease.

[23]  E. Björnsson,et al.  CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis. , 1999, Liver.

[24]  S. Curley,et al.  Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. , 1997, American journal of surgery.

[25]  Roger Williams,et al.  Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. , 1995, Gastroenterology.

[26]  F. Prat,et al.  Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures , 2000, Gut.

[27]  W. Jarnagin,et al.  Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. , 1998, Annals of surgery.

[28]  B. Langer,et al.  Role of US in the detection, characterization, and staging of cholangiocarcinoma. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[29]  F. Muscari Prise en charge du cholangiocarcinome hilaire , 2007 .

[30]  G. Pond,et al.  Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  U. Mansmann,et al.  Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. , 2003, Gastroenterology.

[32]  M. Bloomston,et al.  Location, not Staging, of Cholangiocarcinoma Determines the Role for Adjuvant Chemoradiation Therapy , 2001, The American surgeon.

[33]  G. Gores,et al.  Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma , 2004, Seminars in liver disease.

[34]  T. de Baère,et al.  Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. , 2005, Radiology.

[35]  R. Chuttani,et al.  The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures. , 2001, Gastrointestinal endoscopy.

[36]  M. Choti,et al.  Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. , 2005, Journal of vascular and interventional radiology : JVIR.

[37]  A. Bergquist,et al.  Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. , 2002, Endoscopy.

[38]  C. Meyer,et al.  Liver transplantation for cholangiocarcinoma: results in 207 patients. , 2000, Transplantation.

[39]  R. Parks,et al.  The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma , 2005, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.

[40]  K. McGlynn,et al.  Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.

[41]  W. Chapman,et al.  Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma , 2007, Journal of Gastrointestinal Surgery.

[42]  T. Therneau,et al.  A Comparison of Routine Cytology and Fluorescence in situ Hybridization for the Detection of Malignant Bile Duct Strictures , 2004, The American Journal of Gastroenterology.

[43]  L. Blumgart,et al.  Hilar Cholangiocarcinoma: A Review and Commentary , 2000, Annals of Surgical Oncology.

[44]  C. Charnsangavej,et al.  Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  J. Herman,et al.  Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma , 2005, Modern Pathology.

[46]  G. D. De Palma,et al.  Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. , 2001, Gastrointestinal endoscopy.

[47]  Alphonse E. Sirica,et al.  Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy , 2005, Hepatology.

[48]  S. Selvaggi Biliary brushing cytology , 2004, Cytopathology : official journal of the British Society for Clinical Cytology.

[49]  Z. Aziz,et al.  Gemcitabine and Cisplatin Is a Highly Effective Combination Chemotherapy in Patients With Advanced Cancer of the Gallbladder , 2003, American journal of clinical oncology.